Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002669
Status:
COMPLETED
Last Update Posted:
2012-07-02
First Post:
2000-06-02
Brief Title:
Combination Chemotherapy Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Melanoma
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Organization Data
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Class:
NETWORK
Study ID:
EORTC-18951
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None